Investors accused the healthcare company of putting out false and misleading information in an attempt to hide its struggling LTC pharmacy business ahead of another merger. But the CVS statements and omissions the investors challenged weren’t actionable, the U.S. District Court for the District of Rhode Island said.
CVS allegedly misled investors about its performance and operational success, failed to disclose its loss ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.